As of 2026-03-21, the EV/EBITDA ratio of XBiotech Inc (XBIT) is -2.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XBIT's latest enterprise value is 72.87 mil USD. XBIT's TTM EBITDA according to its financial statements is -34.47 mil USD. Dividing these 2 quantities gives us the above XBIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2026-03-18 | -1.99 |
| 2026-03-17 | -1.99 |
| 2026-03-16 | -2.03 |
| 2026-03-13 | -2.04 |
| 2026-03-12 | -2.07 |
| 2026-03-11 | -2.07 |
| 2026-03-10 | -2.06 |
| 2026-03-09 | -2.08 |
| 2026-03-06 | -2.08 |
| 2026-03-05 | -2.04 |
| 2026-03-04 | -2.08 |
| 2026-03-03 | -2.07 |
| 2026-03-02 | -2.05 |
| 2026-02-27 | -2.00 |
| 2026-02-26 | -2.08 |
| 2026-02-25 | -2.09 |
| 2026-02-24 | -2.07 |
| 2026-02-23 | -2.07 |
| 2026-02-20 | -2.04 |
| 2026-02-19 | -2.11 |
| 2026-02-18 | -2.13 |
| 2026-02-17 | -2.07 |
| 2026-02-13 | -2.17 |
| 2026-02-12 | -2.10 |
| 2026-02-11 | -2.10 |
| 2026-02-10 | -2.14 |
| 2026-02-09 | -2.04 |
| 2026-02-06 | -2.10 |
| 2026-02-05 | -2.03 |
| 2026-02-04 | -2.13 |
| 2026-02-03 | -2.12 |
| 2026-02-02 | -2.19 |
| 2026-01-30 | -2.22 |
| 2026-01-29 | -2.25 |
| 2026-01-28 | -2.34 |
| 2026-01-27 | -2.40 |
| 2026-01-26 | -2.38 |
| 2026-01-23 | -2.37 |
| 2026-01-22 | -2.35 |
| 2026-01-21 | -2.26 |
| 2026-01-20 | -2.24 |
| 2026-01-16 | -2.27 |
| 2026-01-15 | -2.24 |
| 2026-01-14 | -2.31 |
| 2026-01-13 | -2.26 |
| 2026-01-12 | -2.24 |
| 2026-01-09 | -2.26 |
| 2026-01-08 | -2.34 |
| 2026-01-07 | -2.22 |
| 2026-01-06 | -2.24 |